We are developing the devices and systems to contribute to the improvement of the quality of life by integrating nano/micro fabrication technology and biotechnology.
We aim at mRNA-based therapeutics for treating intractable diseases and regenerative medicine.
Our research is principally focused on supramolecular nano-carriers, such as polymeric micelles, vesicles or polyion-complex, that are formed by the self-assembly of block copolymers for the strategic delivery of therapeutics to the diseased site. We have already made significant contributions in the field of oncology by the effective translation of our innovative research into the clinical application and are committed to continue groundbreaking studies to improve overall quality of healthcare.
With an aim to achieve smart healthcare society by in-body hospital, we will conduct several researches: Open innovation management, Regulatory science of nano-medicine, and Business model generation in the field of preventive medicine.
Our main task is to make a monoclonal antibody (mAb) and a hybrid formulation consisting of biomaterial such as mAb and engineering material such as polymeric micelles.
We are developing nanomachies integrated with the functions to visualize the diseased sites and respond to external energy, aiming to realize functional imaging with high sensitivity and resolution and minimally invasive cancer treatment.